Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 840 results for "daiichi sankyo company"

Ranbaxy to be sold to Sun Pharma
Healthcare Finance News

Daiichi Sankyo's moments of glory

Six years ago, when Daiichi Sankyo, the Japanese pharmaceutical giant, concluded the biggest ever foreign acquisition of an Indian manufacturing company by any group in a $4.2 billion cash deal buying the entire 34.82 per cent stake of Malvinder ... The Echo Of India, 6 days ago
Ranbaxy to be sold to Sun Pharma Healthcare Finance News, 1 week ago
Ranbaxy: Lessons and Opportunities PharmaceuticalProcessing, 1 week ago
[x]  

30 images for daiichi sankyo company

4 Traders, 2 weeks ago
Broadway World, 2 weeks ago
Rediff.com, 1 week ago
The Freepress Journal, 1 week ago
Rediff.com, 6 days ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago
4 Traders, 2 months ago
Rediff.com, 1 week ago

Ken Keller Named President, US Commercial, Daiichi Sankyo, Inc.

/PRNewswire/ -- Daiichi Sankyo, Inc. announced today that Ken Keller will join the company as President of its Commercial operations in the United States starting May 1, 2014. In his role, Mr. Keller will be responsible for leading marketing, sales, ...
 BusinessWeek2 days ago Ken Keller Named President, U.S. Commercial, Daiichi Sankyo, Inc.  BioSpace2 days ago
[x]  

Why was Daiichi Sankyo prompted to quit Ranbaxy?

Japanese innovator drugmaker Daiichi Sankyo bought Ranbaxy in 2008 for $4.6 billion with an intention to enter the generics space by acquiring the largest Indian pharma company. However, it faced daunting challenges in the pursuit. A series of ...
 Economic Times1 week ago Daiichi Sankyo Partners With UCSF To Develop Neurodegenerative Drugs  Bioresearch Online1 week ago Daiichi Sankyo, UCSF strike deal to combat neurodegeneration  Fierce Biotech Research1 week ago Series of import bans, loss of credibility made Daiichi cut and run?  Economic Times1 week ago
Business Standard India

DAIICHI SANKYO : Announcement Regarding Merger Between Sun Pharma and Daiichi Sankyo's Subsidiary Ranbaxy and Resulting Change in Subsidiary

For Immediate Release 2014.04.11 Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Corporate ...
 4 Traders1 week ago Top heads to roll soon at Ranbaxy  Business Standard India1 week ago Announcement Regarding Merger Between Sun Pharma and Daiichi Sankyo's Subsidiary Ranbaxy and Resulting Change in Subsidiary  FirstWord Pharma1 week ago DAIICHI SANKYO : Agrees to Vote its Shares in Ranbaxy in Favor of Sun Pharma's Acquisition  4 Traders2 weeks ago
[x]  

Daiichi Sankyo couldn't manage Ranbaxy; it is now in better hands: industry leaders

Sun Pharmaceuticals proposal to acquire Ranbaxy Laboratories is good for the ailing company, which now has a better chance to come out of the mess it is in, according to industry leaders and experts. VCCircle spoke to a cross section of third ...
 VC Circle1 week ago

Daiichi Sankyo Begins Phase 3 Study For Edoxaban

By Estel Grace Masangkay Daiichi Sankyo announced that it has initiated enrollment of patients into the multinational Phase III study ENSURE-AF evaluating the safety and efficacy of edoxaban against enoxaparin and warfarin. The ENSURE-AF is a ...
 Pharmaceutical Online2 weeks ago Daiichi Sankyo initiates patient enrollment in Phase III NVAF study  Individual.com2 weeks ago
Money Control

Ranbaxy Laboratories in focus today

Daiichi Sankyo the parent company of Ranbaxy Laboratories has temporarily suspended shipments of all active pharmaceutical ingredients (API) produced in Toansa and Dewas plants for Ranbaxy.
 Money Control1 month ago Ranbaxy suspends API shipments from Toansa, Dewas plants  Deccan Herald1 month ago Ranbaxy suspends drug ingredient shipments from two plants  Jagran Post1 month ago

DAIICHI SANKYO : Once-Daily Edoxaban Evaluated in Two Subgroup Analyses of East Asian Patients from the Largest Comparative Phase 3 Trials of a Novel Oral...

Once-Daily Edoxaban Evaluated in Two Subgroup Analyses of East Asian Patients from the Largest Comparative Phase 3 Trials of a Novel Oral Anticoagulant By a News Reporter-Staff News Editor at China Weekly News -- Daiichi Sankyo Company, Limited ...
 4 Traders2 weeks ago DAIICHI SANKYO : Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion  4 Traders2 weeks ago Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion  TMC Net2 weeks ago
IT Business Net

Cautionary tale for Japan M in Ranbaxy fail

By Grab Media, a blinkx company Daiichi Sankyo is giving up control of Ranbaxy Laboratories to Sun Pharma for $3.2 billion. Breakingviews' Peter Thal Larsen says it serves as a reminder of what can go wrong in overseas ventures. recommend this ...
 IT Business Net1 week ago

Rising Sun

The takeover of Daiichi Sankyo-owned Ranbaxy, India’s largest pharmaceutical firm, by Sun Pharma in an all-stock deal worth nearly $4 billion is not only the largest deal in pharma in Asia but has catapulted Sun Pharma to becoming the world’s fifth ...
 Asian Age1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less